» Articles » PMID: 17403932

C-Met is Essential for Wound Healing in the Skin

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2007 Apr 4
PMID 17403932
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Wound healing of the skin is a crucial regenerative process in adult mammals. We examined wound healing in conditional mutant mice, in which the c-Met gene that encodes the receptor of hepatocyte growth factor/scatter factor was mutated in the epidermis by cre recombinase. c-Met-deficient keratinocytes were unable to contribute to the reepithelialization of skin wounds. In conditional c-Met mutant mice, wound closure was slightly attenuated, but occurred exclusively by a few (5%) keratinocytes that had escaped recombination. This demonstrates that the wound process selected and amplified residual cells that express a functional c-Met receptor. We also cultured primary keratinocytes from the skin of conditional c-Met mutant mice and examined them in scratch wound assays. Again, closure of scratch wounds occurred by the few remaining c-Met-positive cells. Our data show that c-Met signaling not only controls cell growth and migration during embryogenesis but is also essential for the generation of the hyperproliferative epithelium in skin wounds, and thus for a fundamental regenerative process in the adult.

Citing Articles

MET Activation in Lung Cancer and Response to Targeted Therapies.

Okun S, Lu D, Sew K, Subramaniam A, Lockwood W Cancers (Basel). 2025; 17(2).

PMID: 39858062 PMC: 11764361. DOI: 10.3390/cancers17020281.


Deoxycholic acid aggravates necrotizing enterocolitis through downregulation of mesenchymal-epithelial transition factor expression.

Li H, Lai J, Xiao D, Huang D, Zhang Y, Gu X Braz J Med Biol Res. 2024; 57:e14046.

PMID: 39630809 PMC: 11653493. DOI: 10.1590/1414-431X2024e14046.


The MET Oncogene: An Update on Targeting Strategies.

Gallo S, Folco C, Crepaldi T Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598385 PMC: 11597589. DOI: 10.3390/ph17111473.


MET Oncogene Targeting for Cancer Immunotherapy.

Lombardi A, Sangiolo D, Vigna E Int J Mol Sci. 2024; 25(11).

PMID: 38892318 PMC: 11173045. DOI: 10.3390/ijms25116109.


Growth factors and growth factor gene therapies for treating chronic wounds.

Mullin J, Rahmani E, Kiick K, Sullivan M Bioeng Transl Med. 2024; 9(3):e10642.

PMID: 38818118 PMC: 11135157. DOI: 10.1002/btm2.10642.


References
1.
Weidner K, Hartmann G, Naldini L, Comoglio P, Sachs M, Fonatsch C . Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS. 1993; 65:311-28. View

2.
Sonnenberg E, Weidner K, Birchmeier C . Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis. EXS. 1993; 65:381-94. View

3.
Kawaida K, Matsumoto K, Shimazu H, Nakamura T . Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci U S A. 1994; 91(10):4357-61. PMC: 43784. DOI: 10.1073/pnas.91.10.4357. View

4.
Jung W, Castren E, Odenthal M, Woude G, Ishii T, Dienes H . Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol. 1994; 126(2):485-94. PMC: 2200035. DOI: 10.1083/jcb.126.2.485. View

5.
Hartmann G, Weidner K, Schwarz H, Birchmeier W . The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J Biol Chem. 1994; 269(35):21936-9. View